Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman F Staats

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Nature Materials|January 24, 2018
Vaccine adjuvants: Softness makes it betterHerman F Staats, David J Burkhart
The Journal of Clinical Investigation|May 20, 2014
Which comes first: the antigen or the adjuvant?Sallie R Permar, Herman F Staats
Clinical & Developmental Immunology|August 10, 2011
Cytokines: the future of intranasal vaccine adjuvantsAfton L Thompson, Herman F Staats
Nature Materials|June 24, 2010
Polymer hydrogels: Chaperoning vaccinesHerman F Staats, Kam W Leong
Nature Materials|November 21, 2019
Softness makes it betterHerman F Staats, David J Burkhart
Vaccine|June 19, 2015
Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccinationDulce Bento, Herman F Staats, Olga Borges
AAPS Pharmscitech|January 10, 2008
Novel dry powder preparations of whole inactivated influenza virus for nasal vaccinationRobert J Garmise, Herman F Staats, Anthony J Hickey
International Immunopharmacology|December 13, 2006
Oral immunogenicity of the plant proteinase bromelainLaura P Hale, David J Fitzhugh, Herman F Staats
Journal of Visualized Experiments : Jove|August 16, 2021
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)Chelsea D Landon, Gabriella Dancourt, Vivian Shing, et al.
Allergy|February 13, 2019
Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in miceBrandi T Johnson-Weaver, Gregory D Sempowski, Herman F Staats
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Nature Materials|January 24, 2018
Vaccine adjuvants: Softness makes it betterHerman F Staats, David J Burkhart
The Journal of Clinical Investigation|May 20, 2014
Which comes first: the antigen or the adjuvant?Sallie R Permar, Herman F Staats
Clinical & Developmental Immunology|August 10, 2011
Cytokines: the future of intranasal vaccine adjuvantsAfton L Thompson, Herman F Staats
Nature Materials|June 24, 2010
Polymer hydrogels: Chaperoning vaccinesHerman F Staats, Kam W Leong
Nature Materials|November 21, 2019
Softness makes it betterHerman F Staats, David J Burkhart
Vaccine|June 19, 2015
Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccinationDulce Bento, Herman F Staats, Olga Borges
AAPS Pharmscitech|January 10, 2008
Novel dry powder preparations of whole inactivated influenza virus for nasal vaccinationRobert J Garmise, Herman F Staats, Anthony J Hickey
International Immunopharmacology|December 13, 2006
Oral immunogenicity of the plant proteinase bromelainLaura P Hale, David J Fitzhugh, Herman F Staats
Journal of Visualized Experiments : Jove|August 16, 2021
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)Chelsea D Landon, Gabriella Dancourt, Vivian Shing, et al.
Allergy|February 13, 2019
Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in miceBrandi T Johnson-Weaver, Gregory D Sempowski, Herman F Staats
Pageof 8